5-Acetyl-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine
CAS : 25961-11-9
Ref. 3D-FA147073
5g | Arrêté | ||
10g | Arrêté | ||
25g | Arrêté | ||
50g | Arrêté | ||
100g | Arrêté |
Informations sur le produit
- 1-(3-Chloro-10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)ethanone
- 1-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)ethanone
- 1-(3-Chloro-10,11-dihydrodibenzo[b,f]azepin-5-yl)ethanone
- 247-371-7
- 5-Acetyl-3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine
- 5-Acetyl-3-chloro-10,11-dihydrodibenzo[b,f]azepine
- 5-Acetyl-3-chloroiminodibenzyl
- 5-acetyl-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine
- 5H-Dibenz[b,f]azepine, 5-acetyl-3-chloro-10,11-dihydro-
- ethanone, 1-(3-chloro-10,11-dihydro-5H-dibenz[b,f]azepin-5-yl)-
- Voir d'autres synonymes
5-Acetyl-3-chloro-10,11-dihydro-5H-dibenz[b,f]azepine (PCDA) is a conformationally restricted analog of dibenz[b,f]azepine. PCDA has been shown to have an azepine crystal structure with a dihedral angle of 11.6 degrees. This compound is believed to be more potent than the parent molecule in inhibiting the production of inflammatory cytokines such as IL1β and TNFα.